General

Showing 849–864 of 1288 results

Article: Nivolumab improves survival in non-squamous NSCLC
€3.03 Add to cart
Article: Nivolumab plus cabozantinib as new first-line treatment option for advanced renal cell carcinoma
€3.03 Add to cart
Article: Nivolumab plus chemotherapy as a potential new standard first-line treatment option for patients with advanced gastric and oesophageal cancers
€3.03 Add to cart
Article: Nivolumab prolongs the survival of patients with advanced renal cell cancer
€3.03 Add to cart
Article: Nivolumab/ipilimumab-induced cerebral vasculitis in stage IIIc melanoma: A case report
€3.03 Add to cart
Article: Non-muscle myosin IIA, a new potential molecular target to improve radiotherapy outcome for breast cancer patients
€3.03 Add to cart
Article: Not just a ‘usual’ Li-Fraumeni syndrome
€3.03 Add to cart
Article: Novel strategies in the management of high-risk and oligometastatic prostate cancer
€3.03 Add to cart
Article: Novel therapeutic molecular targets in lung cancer: non-V600 mutant and mutant
€3.03 Add to cart
Article: Novel, rationally designed combination strategies, based on (phospho)-proteomic analyses, to enhance the response to cetuximab therapy in head and neck cancer
€3.03 Add to cart
Article: O.01 Circulating Tumour Cells and Survival in Abiraterone- and Enzalutamide-treated Patients with Castration-Resistant Prostate Cancer
€3.03 Add to cart
Article: O.01 IDENTIFICATION, CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF SOMATIC HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) MUTATIONS IN METASTATIC BREAST CANCER PATIENTS
€3.03 Add to cart
Article: O.02 Immuno-FIELT: The role of Tumor Infiltrating Lymphocytes and PD-L1 expression in NSCLC adenocarcinoma in little to non-smokers and its relationship with driver mutations and clinical outcome parameters
€3.03 Add to cart
Article: O.02 REAL-LIFE TREATMENT PRACTICE FOR MALIGNANT PLEURAL MESOTHELIOMA IN BELGIUM
€3.03 Add to cart
Article: O.03 DETECTION OF AR PERTURBATIONS IN CIRCULATING TUMOUR CELLS AND CELL-FREE DNA FROM PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PREDICTS RESISTANCE TO ENDOCRINE THERAPY
€3.03 Add to cart
Article: O.03 Identification of candidate breast cancer predisposition genes by sequencing extended panel of 492 cancer associated genes in BRCA1/2 negative probands
€3.03 Add to cart

Article: Nivolumab improves survival in non-squamous NSCLC

Article: Nivolumab plus cabozantinib as new first-line treatment option for advanced renal cell carcinoma

Article: Nivolumab plus chemotherapy as a potential new standard first-line treatment option for patients with advanced gastric and oesophageal cancers

Article: Nivolumab prolongs the survival of patients with advanced renal cell cancer

Article: Nivolumab/ipilimumab-induced cerebral vasculitis in stage IIIc melanoma: A case report

Article: Non-muscle myosin IIA, a new potential molecular target to improve radiotherapy outcome for breast cancer patients

Article: Not just a ‘usual’ Li-Fraumeni syndrome

Article: Novel strategies in the management of high-risk and oligometastatic prostate cancer

Article: Novel therapeutic molecular targets in lung cancer: non-V600 mutant and mutant

Article: Novel, rationally designed combination strategies, based on (phospho)-proteomic analyses, to enhance the response to cetuximab therapy in head and neck cancer

Article: O.01 Circulating Tumour Cells and Survival in Abiraterone- and Enzalutamide-treated Patients with Castration-Resistant Prostate Cancer

Article: O.01 IDENTIFICATION, CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF SOMATIC HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) MUTATIONS IN METASTATIC BREAST CANCER PATIENTS

Article: O.02 Immuno-FIELT: The role of Tumor Infiltrating Lymphocytes and PD-L1 expression in NSCLC adenocarcinoma in little to non-smokers and its relationship with driver mutations and clinical outcome parameters

Article: O.02 REAL-LIFE TREATMENT PRACTICE FOR MALIGNANT PLEURAL MESOTHELIOMA IN BELGIUM

Article: O.03 DETECTION OF AR PERTURBATIONS IN CIRCULATING TUMOUR CELLS AND CELL-FREE DNA FROM PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PREDICTS RESISTANCE TO ENDOCRINE THERAPY

Article: O.03 Identification of candidate breast cancer predisposition genes by sequencing extended panel of 492 cancer associated genes in BRCA1/2 negative probands